《Table 1Basal characteristics of patients who underwent ABO-I LDLT.》

《Table 1Basal characteristics of patients who underwent ABO-I LDLT.》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
Values are presented as number(%),mean±SD or median(interquartile range).ABO-I:ABO-incompatible;BMI:body mass index;HBV:hepatitis B virus;HCC:hepatocellular carcinoma;HCV:hepatitis C virus;INR:international normalized ratio;LDLT:living donor liver tr

B cell subpopulations were not different in the two groups at the time of initial point(P=0.657)and ABO-I LDLT(P=0.079).Plasmapheresis was performed a median of 2 times(1–2.3)before surgery in the RP group(Table 1).